PHM — Pharma Mar SA Cashflow Statement
0.000.00%
Last trade - 00:00- €1.53bn
- €1.42bn
- €221.39m
Annual cashflow statement for Pharma Mar SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 95.1 | 43.8 | -3.62 | 12 | 59.7 |
| Depreciation | |||||
| Non-Cash Items | -2.76 | 15.6 | 1.07 | -7.44 | -4.05 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -72.3 | -27 | -16.6 | -5.29 | -10.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 25.7 | 38.3 | -13.4 | 6.03 | 53.1 |
| Capital Expenditures | -7.8 | -8.85 | -16 | -15.5 | -9.38 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 26.3 | 19.7 | -27.1 | 16.5 | -51.4 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 18.5 | 10.9 | -43 | 1.03 | -60.8 |
| Financing Cash Flow Items | 0 | — | — | -0.938 | -0.955 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -27.4 | -13.4 | -32.1 | -5.35 | -36.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.1 | 36.5 | -89.8 | 3.21 | -45.4 |